Results 311 to 320 of about 205,182 (367)

Cancer treatment and survivorship statistics, 2025

open access: yesCA: A Cancer Journal for Clinicians, EarlyView.
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle   +9 more
wiley   +1 more source

Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study. [PDF]

open access: yesSci Rep
Jung J   +13 more
europepmc   +1 more source

Autoimmune Diseases: Molecular Pathogenesis and Therapeutic Targets

open access: yesMedComm, Volume 6, Issue 7, July 2025.
This review provides a comprehensive overview of common autoimmune diseases, details clinical manifestations and summarizes the pathogenesis, including the breakdown of immune tolerance, initiation of autoimmune responses, and their progressive amplification.
Xiaoshuang Song   +9 more
wiley   +1 more source

Barriers to Hematopoietic Stem Cell Transplant Among Caregivers and Adolescents With Sickle Cell Disease

open access: yesPediatric Blood &Cancer, Volume 72, Issue 7, July 2025.
ABSTRACT Background Hematopoietic stem cell transplantation (HSCT) is a curative treatment for sickle cell disease (SCD). However, barriers exist that prevent access to this treatment modality. Methods An IRB‐approved mixed‐method survey of barriers to HSCT in SCD was given to parents, caregivers, and adolescents obtaining care at the Children's of ...
Chibuzo Ilonze   +4 more
wiley   +1 more source

Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review. [PDF]

open access: yesCNS Oncol
Griffith-Linsley J   +7 more
europepmc   +1 more source

Cell-based meniscus tissue engineering [PDF]

open access: yes, 2007
Elewaut, Dirk   +4 more
core   +1 more source

Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab‐, Elotuzumab‐, and Carfilzomib‐Based Triplet Regimens: A Multicenter Real‐World Analysis of 635 Patients

open access: yesEuropean Journal of Haematology, Volume 115, Issue 1, Page 16-28, July 2025.
ABSTRACT Relapsed/refractory multiple myeloma (RRMM) research on the impact of +1q abnormalities in real‐world settings is limited. This study evaluated the prognostic and predictive significance of 1q gain [gain(1q)] and amplification [ampl(1q)] in 635 RRMM patients treated with daratumumab‐, elotuzumab‐, and carfilzomib‐based triplet regimens ...
Fortunato Morabito   +66 more
wiley   +1 more source

Impact of second autologous stem-cell transplantation at relapsed multiple myeloma: A French multicentric real-life study. [PDF]

open access: yesHemasphere
André A   +15 more
europepmc   +1 more source

Salvage Treatment for Extragonadal Germ Cell Tumours: High-Dose Chemotherapy and Autologous Stem Cell Transplantation Outcomes-A Single-Centre Experience. [PDF]

open access: yesJ Clin Med
Topal A   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy